THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS

Among the most important aspects of the health policy are the methods for pricing of medicines, especially of innovative medicines. In many countries, the “therapeutic value” of a medicine is commonly used as a major criterion in negotiations on medicine prices. The existing tools for assessing the...

Descrizione completa

Dettagli Bibliografici

Autori principali:	V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	IRBIS LLC 2017-08-01
Serie:	Фармакоэкономика
Soggetti:	value-based pricing innovative medicines innovations multi-criteria decision analysis mcda
Accesso online:	https://www.pharmacoeconomics.ru/jour/article/view/200
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!